This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ruixue Wang: Innovator in Cancer Treatment
Introduction
Ruixue Wang is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of novel therapeutic agents.
Latest Patents
Ruixue Wang holds a patent titled "High Affinity Nanobodies Targeting B7-H3 (CD276) for Treating Multiple Solid Tumors." This patent represents her groundbreaking work in targeting specific proteins associated with various solid tumors, showcasing her commitment to advancing cancer therapies. She has 1 patent to her name.
Career Highlights
Wang is affiliated with the United States of America, as Represented by the Secretary, Department of Health and Human Services. Her work has been instrumental in developing new strategies for cancer treatment, particularly through the use of nanobodies.
Collaborations
Ruixue Wang has collaborated with notable colleagues, including Mitchell Ho and Bradley St Croix. These partnerships have enhanced her research efforts and contributed to the advancement of cancer treatment methodologies.
Conclusion
Ruixue Wang's innovative work in cancer treatment exemplifies her dedication to improving patient outcomes through scientific research. Her contributions are paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile